CD34 and diabetes mellitus: We also observed a decreased percentage of CPCs (CD34+CD133+CXCR4+), which are also reported to contribute to revascularization potential, adult vasculogenesis, and correlate with cardiovascular outcomes in DM patients (23, 52–54).